相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of PLA2G6 as a Locus for Dystonia-Parkinsonism
Coro Paisan-Ruiz et al.
ANNALS OF NEUROLOGY (2009)
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Nathan Pankratz et al.
HUMAN GENETICS (2009)
Lack of replication of association between GIGYF2 variants and Parkinson disease
Jose Bras et al.
HUMAN MOLECULAR GENETICS (2009)
ATP13A2 Variability in Parkinson Disease
Carles Vilarino-Guell et al.
HUMAN MUTATION (2009)
Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation
Hui Xiong et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome
A. Di Fonzo et al.
NEUROLOGY (2009)
Variation in GIGYF2 is not associated with Parkinson disease
W. C. Nichols et al.
NEUROLOGY (2009)
Treatments for Parkinson disease-past achievements and current clinical needs
Werner Poewe
NEUROLOGY (2009)
Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population
R. Myhre et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease
Corinne Lautier et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Mitochondrial Function and Morphology Are Impaired in parkin-Mutant Fibroblasts
Heather Mortiboys et al.
ANNALS OF NEUROLOGY (2008)
Glucocerebrosidase gene mutations - A risk factor for Lewy body disorders
Ignacio F. Mata et al.
ARCHIVES OF NEUROLOGY (2008)
Cell systems and the toxic mechanism(s) of alpha-synuclein
Mark R. Cookson et al.
EXPERIMENTAL NEUROLOGY (2008)
Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain
Julia Fuchs et al.
FASEB JOURNAL (2008)
Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation
Juergen Prestel et al.
JOURNAL OF NEUROLOGY (2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Anthony H. V. Schapira
LANCET NEUROLOGY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy
Elvira V. De Marco et al.
MOVEMENT DISORDERS (2008)
The PINK1/Parkin pathway regulates mitochondrial morphology
Angela C. Poole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
α-Synuclein and Parkinson disease susceptibility
S. Winkler et al.
NEUROLOGY (2007)
Mono- and double-mutant mouse models of Parkinson's!disease display severe mitochondrial damage
Christine C. Stichel et al.
HUMAN MOLECULAR GENETICS (2007)
Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels
Monica Joch et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease
An Goris et al.
ANNALS OF NEUROLOGY (2007)
Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1
Elisa Greggio et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain
Shinji Higashi et al.
BRAIN RESEARCH (2007)
Familial genes in sporadic disease:: Common variants of α-synuclein gene associate with Parkinson's disease
Owen A. Ross et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions
Justus C. Dachsel et al.
ACTA NEUROPATHOLOGICA (2007)
Evaluation of LRRK2 G2019S penetrance -: Relevance for genetic counseling in Parkinson disease
S. Goldwurm et al.
NEUROLOGY (2007)
Neuropsychiatric and cognitive features in autosomal-recessive early Parkinsonism due to PINK1 mutations
Lilach Ephraty et al.
MOVEMENT DISORDERS (2007)
Leucine-Rich Repeat kinase 2 G238SR variant is a risk factor for Parkinson disease in Asian population
Manabu Funayama et al.
NEUROREPORT (2007)
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
Hans-Hermann Hoepken et al.
NEUROBIOLOGY OF DISEASE (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease
Shira G. Ziegler et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients
Denise M. Kay et al.
ANNALS OF NEUROLOGY (2007)
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Matthew J. Farrer et al.
PARKINSONISM & RELATED DISORDERS (2007)
Update on the genetics of Parkinson's disease
Thomas Gasser
MOVEMENT DISORDERS (2007)
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence
E. K. Tan et al.
HUMAN GENETICS (2007)
Digenic parkinsonism:: Investigation of the synergistic effects of PRKN and LRRK2
Justus C. Dachsel et al.
NEUROSCIENCE LETTERS (2006)
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Alfredo Ramirez et al.
NATURE GENETICS (2006)
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
O. Goker-Alpan et al.
NEUROLOGY (2006)
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease
Demetrius M. Maraganore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused inactivation of Drosophila Pink1 is rescued by by Parkin
Yufeng Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The sepiapterin reductase gene region reveals association in the PARK3 locus:: analysis of familial and sporadic Parkinson's disease in European populations
M. Sharma et al.
JOURNAL OF MEDICAL GENETICS (2006)
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron
Neil V. Morgan et al.
NATURE GENETICS (2006)
A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan
Alessio Di Fonzo et al.
NEUROGENETICS (2006)
Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease : Role of a single hit?
Katja Hedrich et al.
ARCHIVES OF NEUROLOGY (2006)
Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease
I Mizuta et al.
HUMAN MOLECULAR GENETICS (2006)
Parkin enhances mitochondrial biogenesis in proliferating cells
Y Kuroda et al.
HUMAN MOLECULAR GENETICS (2006)
Interface between tauopathies and synucleinopathies: A tale of two proteins
WR Galpern et al.
ANNALS OF NEUROLOGY (2006)
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease
A Di Fonzo et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
S Lesage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
Role of DJ-1 in Parkinson's disease
Nirit Lev et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
WW Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lrrk2 pathogenic substitutions in Parkinson's disease
IF Mata et al.
NEUROGENETICS (2005)
G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort
JM Bras et al.
MOVEMENT DISORDERS (2005)
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex
G Annesi et al.
ANNALS OF NEUROLOGY (2005)
Alpha-synuclein and Parkinson's disease:: Implications from the screening of more than 1,900 patients
D Berg et al.
MOVEMENT DISORDERS (2005)
Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers
PP Pramstaller et al.
ANNALS OF NEUROLOGY (2005)
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
KM Strauss et al.
HUMAN MOLECULAR GENETICS (2005)
Early-onset parkinsonism associated with PINK1 mutations -: Frequency, genotypes, and phenotypes
V Bonifati et al.
NEUROLOGY (2005)
The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease
A Albanese et al.
NEUROLOGY (2005)
Multiple regions of α-synuclein are associated with Parkinson's disease
JC Mueller et al.
ANNALS OF NEUROLOGY (2005)
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations
J Kachergus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Regulation of α-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene
O Chiba-Falek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
PARK11 is not linked with Parkinson's disease in European families
J Prestel et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice
JJ Palacino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
UCHL1 is a Parkinson's disease susceptibility gene
DM Maraganore et al.
ANNALS OF NEUROLOGY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Distribution, type, and origin of Parkin mutations:: Review and case studies
K Hedrich et al.
MOVEMENT DISORDERS (2004)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
PINK1 mutations are associated with sporadic early-onset parkinsonism
EM Valente et al.
ANNALS OF NEUROLOGY (2004)
Novel PINK1 mutations in early-onset parkinsonism
Y Hatano et al.
ANNALS OF NEUROLOGY (2004)
Tau gene and Parkinson's disease: a case-control study and meta-analysis
DG Healy et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews
J Aharon-Peretz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
RM Canet-Avilés et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
DW Miller et al.
NEUROLOGY (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Linkage disequilibrium and association of MAPT H1 in Parkinson disease
L Skipper et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Genes influencing Parkinson disease onset -: Replication of PARK3 and identification of novel loci
N Pankratz et al.
NEUROLOGY (2004)
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
R Hering et al.
HUMAN MUTATION (2004)
A haplotype at the PARK3 locus influences onset age for Parkinson's disease -: The GenePD study
S Karamohamed et al.
NEUROLOGY (2003)
Roc, a Ras/GTPase domain in complex proteins
L Bosgraaf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
The role of pathogenic DJ-1 mutations in Parkinson's disease
PM Abou-Sleiman et al.
ANNALS OF NEUROLOGY (2003)
Parkin mutations are frequent in patients with isolated early-onset parkinsonism
M Periquet et al.
BRAIN (2003)
Significant linkage of Parkinson disease to chromosome 2q36-37
N Pankratz et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
JC Greene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Parkin variants in north American Parkinson's disease: Cases and controls
SJ Lincoln et al.
MOVEMENT DISORDERS (2003)
A susceptibility gene for late-onset idiopathic Parkinson's disease
AA Hicks et al.
ANNALS OF NEUROLOGY (2002)
Progression of nigrostriatal dysfunction in a parkin kindred:: an [18F] dopa PET and clinical study
NL Khan et al.
BRAIN (2002)
The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease
R de Silva et al.
NEUROSCIENCE LETTERS (2002)
Concurrence of α-synuclein and tau brain pathology in the Contursi kindred
JE Duda et al.
ACTA NEUROPATHOLOGICA (2002)
PARK3 influences age at onset in Parkinson disease:: A genome scan in the GenePD study
AL DeStefano et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease
PK Auluck et al.
SCIENCE (2002)
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
M Funayama et al.
ANNALS OF NEUROLOGY (2002)
Phenotypic variability in a large kindred (Family LA) with deletions in the parkin gene
PP Pramstaller et al.
MOVEMENT DISORDERS (2002)
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease
ER Martin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease
KKK Chung et al.
NATURE MEDICINE (2001)
Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations
CB Lücking et al.
NEUROLOGY (2001)
Lewy bodies and parkinsonism in families with parkin mutations
M Farrer et al.
ANNALS OF NEUROLOGY (2001)
An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin
Y Imai et al.
CELL (2001)
Origin of the mutations in the parkin gene in europe:: Exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects
M Periquet et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
BPC van de Warrenburg et al.
NEUROLOGY (2001)
Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
H Shimura et al.
NATURE GENETICS (2000)
Association between early-onset Parkinson's disease and mutations in the parkin gene
CB Lücking et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
分享论文
